Health

“Golf Healing” column by “Lt. More than 30 years of patient care experience [email protected]

“It’s here now, can you take off the mask or have you seen him say Covid is calm, right, doctor?”

“No sir, don’t trust anything else, there’s still a lot of PM dust,” the doctor replied to Khun Chu Sanga with concern.

“Who is it better to believe than to believe Yong? Well, Master Mo Yong, how are you?”

“Doctor Yong, you already told me game over.” Chao Keng jams in once more as usual.

Prof. Dr. Yong Phuwarawan has posted a summary of the 3-year lesson that COVID-19 has made it possible to see the truth, summarized as a body of knowledge as follows:

1. The virus evolves to survive. by adjusting to reduce the violence to be able to live with the host Therefore, the severity of COVID-19 has always decreased. From a high mortality rate of 3-5% until now it should be less than 0.1%, like influenza.

2. Diseases with high severity, such as Ebola, etc., are unlikely to spread throughout the world. As opposed to low-severity diseases such as influenza, COVID-19 can spread worldwide.

3. Each type of vaccine is not different from those who believe and claim that the mrna vaccine can stimulate high immunity. However, following long-term efficacy, the immune system declines rapidly and becomes unable to resist infection. The mortality rates in countries where mRNA injections were not lower than those in non-injecting countries. Therefore, in the past, there was no Thep vaccine. And now many companies have reduced production or stopped production altogether.

4. Outbreaks are reduced. Because most of the population in each country has already been infected by more than 70 percent, thus reducing the outbreak.

5. Immunity resulting from infection with vaccination is relatively complete and lasts longer than immunity from vaccine alone.

6. The direction of the outbreak when entering a seasonal disease, the outbreak is the same as influenza or general respiratory disease.

7. The necessity of future vaccines is similar to influenza, that is, it will focus only on risk groups who are infected and will have severe symptoms in people who have been infected before or people who are healthy, even if re-infected, the symptoms will not be severe.

8. To solve the epidemic problem, if we might go back in time, we should use knowledge to create knowledge instead of following the current or pressure from social media.

9. This year, Game Over will have to believe that the World Health Organization will stop counting numbers. Because the numbers reported in the World Health Organization and for all countries of infection are much lower than reality and everything is on surveillance and the outbreak is seasonal.

10. For Thailand, as Dr. Yong said since the end of last year, from February onwards, the disease will be calm and will be found once more in June to September and following that it will be a seasonal outbreak cycle.

Wednesday, March 1, 2023 – 8:32 PM

Muhammad Nabil Abu Taha / Ahmed Zahran / Asim Al-Khouli

Follow our coverage of the NHL trade deadline on Friday at 6 a.m. on RDS and RDS.ca.

Transaction table

The Detroit Red Wings seem poised to approach the NHL trade deadline as sellers.

According to our collaborator Pierre LeBrun, the Wings might even be open to trading more than just their players who will soon be eligible for full autonomy.

Tuesday, the result of a second straight loss to the Ottawa Senators, Detroit (28-24-8) slipped a little further in the race for the drafted teams, five points behind the place they held last week .

LeBrun reports that general manager Steve Yzerman wants to trade forwards Tyler Bertuzzi (who will be free as air in July) and Jakub Vrana, while there is also a possibility that Filip Zadina will change address.

“The Red Wings currently recognize that the race in the East is tough, if not too tough. They can’t afford to let Bertuzzi slip away towards autonomy without getting anything. It is in this perspective that they wish to exchange them, Vrana and him. Zadina is a name that is also discussed internally; he’s a 23-year-old forward with two more years on his contract. »

The 28-year-old Bertuzzi has 14 points (4-10) in 29 games this season, having been injured early in the season. His salary accounts for $4.75 million on his club’s payroll.

After seeking help from the NHL Assistance Program and the Players’ Association early in the season, Vrana had two points in five games with Detroit.

In 2019 and 2020, Vrana, who is 27, had two consecutive 20+ goal seasons. His agreement, at $5.25 million per year, is valid until the end of the 2023-2024 calendar.

In 179 NHL games, Zadina, a former sixth overall pick, has 27 goals and 65 points. He pockets a salary of $ 1.825 million as part of a three-season pact signed in August 2022.

Edmonton: Offensive help now?

The Edmonton Oilers made one of the biggest catches of the day on Tuesday with the acquisition of defenseman Mattias Ekholm from the Nashville Predators.

It would seem that the Alberta team are now turning to the forward market.

Pierre LeBrun says Bertuzzi, along with Arizona Coyotes center Nick Bjugstad, are among the options general manager Ken Holland is considering.

The 30-year-old Bjugstad has 13 goals and 23 points in 59 games for Arizona this season. It’s the first time he’s scored 10 or more goals since producing 19 goals in 2017-18 at Florida.

Bjugstad’s salary, which will qualify for full autonomy, is $900,000.

The Wings are expected to demand a first-round pick for Bertuzzi’s services. The Oilers traded their first selection of 2023 to the Preds, but still own those from the 2024 and 2025 auctions.

JVR in the West?

The market continues to heat up for Philadelphia Flyers full-size winger James van Riemsdyk.

LeBrun says the Vegas Golden Knights, Winnipeg Jets and Calgary Flames have all shown interest in the American forward.

“Suddenly the Flyers are getting a high volume of calls for JVR, given the roster of players who are no longer available. Vegas is one of those clubs that calls, as well as Minnesota, but I imagine the additions of Marcus Johansson and Gustav Nyquist are a game-changer. Winnipeg and Calgary have also shown interest in van Riemsdyk. »

“If you look at what Seattle got last year for Calle Jarnkrok, a second and a third pick…I think that’s the kind of return the Flyers can expect,” said he specified.

Last week, his TSN colleague Chris Johnston suggested that Philadelphia is willing to withhold part of JVR’s remaining salary, which is $7 million. His deal ends in the summer of 2023.

In his second appearance with the Philly organization, JVR has 23 points including nine goals in 40 games this season. The Flyers are on track to miss the playoffs for the third straight season.

Flyers take calls for Provorov

According to our colleague Darren Dreger of TSN, the Flyers would take calls regarding Ivan Provorov.

Dreger said a trade for a defenseman of that caliber would be expensive since Provorov still has two more years left on his $6.75 million contract at the end of the season.

At 26, Provorov has four goals and 22 points in 61 games with the Flyers this season.

He was selected seventh overall in the 2015 draft. He also had 212 points in 511 games in his career in Philadelphia.

[현대건강신문=여혜숙 기자] An analysis showed that the risk of developing shingles may increase significantly following vaccination with Corona 19. However, it is pointed out that a review of clinical significance is necessary as no significance was found in the analysis by vaccine order.

The National Academy of Medicine of the Republic of Korea (Director Kyu-Chang Wang), established with the goal of evaluating the causality of adverse events following vaccination with the Corona 19 vaccine, held the 3rd forum on the 28th following the 1st and 2nd forums. .

In this forum, research analysis on the association between COVID-19 vaccination and deep vein thrombosis (without thrombocytopenia), pulmonary embolism, shingles, and multiple sclerosis was explained.

First, as a result of confirming the association between corona 19 vaccination and ‘deep vein thrombosis (without thrombocytopenia) and pulmonary embolism’, it was difficult to confirm causality.

Gachon University Gil Hospital Professor Jeong Jae-hoon of the department of infectious medicine said, “There is no evidence to support causality in deep vein thrombosis in the previous analysis. Therefore, in this reanalysis, we evaluated the statistical relevance of domestic COVID-19 vaccination and deep vein thrombosis and pulmonary embolism by utilizing strict case definitions and two independent research methodologies.” An increase in the incidence of deep vein thrombosis and pulmonary embolism was not observed. This is consistent with the results of a number of studies conducted overseas and a meta-analysis that synthesized them.”

The association between vaccination once morest Corona 19 and the occurrence of shingles can be somewhat increased, but additional research is needed.

Cases of shingles following diagnosis of COVID-19 and cases of reactivation of the shingles virus following vaccination with COVID-19 were reported around the world, and it was necessary to conduct epidemiological analysis to determine the safety of vaccines according to the number of vaccines and vaccine types in Korea. .

To evaluate the association between the COVID-19 vaccine and herpes zoster, we checked the incidence of herpes zoster in Korea for regarding 10 years, and compared the expected and observed incidence rates of herpes zoster following vaccination with the COVID-19 vaccine.

In addition, using the Self-Controlled Case Series (SCCS) design, the ‘risk interval (1–28 days following vaccination)’ and In the event of shingles, the ‘control period (period excluding the risk period within the observation period)’, which is expected to be unrelated to the vaccine, was compared.

Professor Sohn Hyo-joo of the Department of Infectious Diseases at Uijeongbu Eulji University Hospital said, “As a result of the study, the crude incidence rate per 100,000 population has been continuously increasing since 2013, with 1164.1 in 2020 and 1211.2 in 2021. As a result of the SCCS analysis, the risk of developing shingles within 28 days following vaccination was found to increase significantly by 1.1 times.”

However, he explained that there was no significance in the analysis of each vaccine sequence, so it is necessary to review the clinical significance.

Professor Sohn said, “A significant increase in risk was observed in age groups and chronic disease companions in the small group analysis, indicating the need to manage risk factors for common shingles.” is needed,” he said.

Due to the lack of safety evidence for the relationship between COVID-19 vaccination and multiple sclerosis, an epidemiological analysis was performed on the risk of multiple sclerosis following vaccination in the entire population of Korea.

A self-control study design was applied to evaluate the association between COVID-19 vaccine and multiple sclerosis. When the observation period was 270 days following vaccination with COVID-19 vaccine and the risk interval was set as 1 to 30 days or 1 to 60 days following vaccination, the risk of occurrence was 0.91 and 0.71 times, respectively, compared to the control group, but statistically significant. Did not do it.

Even when sensitivity analysis was performed with various operational definitions of patients with multiple sclerosis, no increase in the risk of multiple sclerosis was observed following vaccination with the COVID-19 vaccine. There was no statistical significance in the results of subgroup analysis according to gender, age, type of vaccine recently received before onset, and comorbidity score.

Professor Kim Yoo-hwan of the Department of Neurology at Hallym University Sacred Heart Hospital said, “Considering the results of this study and the review of literature, the scientific evidence to date has been evaluated as insufficient to admit or deny the causality between the COVID-19 vaccine and multiple sclerosis. “he said.

“At this forum, we presented research and analysis results related to deep vein thrombosis, herpes zoster, and multiple sclerosis, which are of high interest to the public,” said Park Byeong-joo, head of the COVID-19 Vaccine Safety Research Center. showed that vaccination with Corona 19 did not increase the risk of occurrence, and shingles appeared to slightly increase the risk of occurrence, but additional research is needed for clinical significance.”

In addition, “I deeply sympathize with the pain and frustration of those who have suffered from adverse reactions since the corona 19 vaccine, and I especially offer deep consolation to those who have died and their families. We will continue to make efforts to make more accurate results in terms of scientific causality through continuous research on various diseases.”